| |
| |
|
| Insider
Information: |
Valliant John |
| Relationship: |
Chief Executive Office... |
| City: |
Hamilton |
| State: |
A6 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
318,147 |
|
|
Indirect Shares
|
531,934 |
|
|
| Direct
Value |
$6,833,798 |
|
|
|
Indirect Value
|
$11,425,942 |
|
|
| Total
Shares |
850,081 |
|
|
| Total
Value |
$18,259,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fusion Pharmaceuticals Inc. |
FUSN |
Chief Executive Office... |
2022-04-27 |
318,147 |
2020-06-25 |
531,934 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-15 |
4 |
AS |
$8.33 |
$104,958 |
D/D |
(12,600) |
519,334 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-16 |
4 |
AS |
$7.99 |
$265,284 |
D/D |
(33,202) |
486,132 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-17 |
4 |
AS |
$7.98 |
$13,566 |
D/D |
(1,700) |
484,432 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-18 |
4 |
AS |
$7.88 |
$38,596 |
D/D |
(4,898) |
479,534 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-22 |
4 |
AS |
$7.85 |
$32,185 |
D/D |
(4,100) |
475,434 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-23 |
4 |
AS |
$7.77 |
$227,653 |
D/D |
(29,299) |
446,135 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-24 |
4 |
AS |
$7.41 |
$18,525 |
D/D |
(2,500) |
443,635 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-25 |
4 |
AS |
$7.57 |
$61,711 |
D/D |
(8,152) |
435,483 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-28 |
4 |
AS |
$7.40 |
$22,940 |
D/D |
(3,100) |
432,383 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-01 |
4 |
AS |
$7.37 |
$6,242 |
D/D |
(847) |
431,536 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-02 |
4 |
AS |
$7.44 |
$197,502 |
D/D |
(26,546) |
404,990 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-03 |
4 |
AS |
$7.28 |
$1,456 |
D/D |
(200) |
404,790 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-04 |
4 |
AS |
$7.32 |
$61,488 |
D/D |
(8,400) |
396,390 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-07 |
4 |
AS |
$6.99 |
$21,669 |
D/D |
(3,100) |
393,290 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-08 |
4 |
AS |
$6.92 |
$20,788 |
D/D |
(3,004) |
390,286 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-09 |
4 |
AS |
$6.94 |
$5,705 |
D/D |
(822) |
389,464 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-10 |
4 |
AS |
$7.06 |
$13,414 |
D/D |
(1,900) |
387,564 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
AS |
$7.13 |
$713 |
D/D |
(100) |
387,464 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-14 |
4 |
AS |
$6.96 |
$9,048 |
D/D |
(1,300) |
386,164 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-15 |
4 |
AS |
$7.12 |
$712 |
D/D |
(100) |
386,064 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-16 |
4 |
AS |
$6.99 |
$699 |
D/D |
(100) |
385,964 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-17 |
4 |
AS |
$7.51 |
$6,759 |
D/D |
(900) |
385,064 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-18 |
4 |
AS |
$7.61 |
$9,162 |
D/D |
(1,204) |
383,860 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-21 |
4 |
AS |
$7.47 |
$11,205 |
D/D |
(1,500) |
382,360 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-21 |
4 |
AS |
$7.46 |
$5,222 |
D/D |
(700) |
377,560 |
0 |
% |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
